3-[(2-Chlorothiazol-5-yl)methyl]-5-(isobutylamino)-6-phenyl-3H-1,2,3-triazolo[4,5-d]pyrimidin-7(6H)-one
✍ Scribed by Xiao, Lin-Xia ;Shi, De-Qing
- Publisher
- International Union of Crystallography
- Year
- 2007
- Tongue
- English
- Weight
- 559 KB
- Volume
- 63
- Category
- Article
- ISSN
- 1600-5368
No coin nor oath required. For personal study only.
✦ Synopsis
The title compound, C 18 H 18 ClN 7 OS, the mean plane of the triazolopyrimidine system makes dihedral angles of 77.54 (13) and 80.15 (13) , respectively, with the attached phenyl and 2chlorothiazole rings. The crystal packing is stabilized by intermolecular N-HÁ Á ÁN hydrogen bonds and weakstacking interactions [the interplanar distance is 3.724 ( 2) A ˚]. = 101.527 (2) V = 4005.0 (6) A ˚3 Z = 8 Mo K radiation = 0.32 mm À1 T = 294 (2) K 0.20 Â 0.10 Â 0.04 mm Data collection Bruker SMART APEX CCD areadetector diffractometer Absorption correction: multi-scan (SADABS; Sheldrick, 2001) T min = 0.939, T max = 0.987 17095 measured reflections 4343 independent reflections 2226 reflections with I > 2(I) R int = 0.096 Refinement R[F 2 > 2(F 2 )] = 0.064 wR(F 2 ) = 0.143 S = 0.98 4343 reflections
📜 SIMILAR VOLUMES
In the structure of the title compound, C 21 H 17 FN 4 O 2 S 2 , the fused thiazolopyrimidine ring system is nearly planar. The morpholine ring adopts a chair conformation. The crystal structure is stabilized by C-HÁ Á ÁO hydrogen bonds and weak stacking interactions.